NEW YORK STOCK EXCHANGE, INC. · DGX

+1.54% · +$3.59 · Vol 926.9K

Market closed · last close 4:00 PM ET · price as of 19:00:00 ET

Quest Diagnostics Inc

Health Care

$236.59

Card

Relationship Map

Follow $DGX

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $DGX by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measured

Thu Sep 24 · market closed · Markets closed · resumes Fri 9:30 ET · DGX

Methodology

DGX

Quest Diagnostics Inc

Thu Sep 24 · market closed · Markets closed · resumes Fri 9:30 ET

75/100

Highest qualified

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

75/ 100

Veridion Score

Highest qualified · HIGH confidence · 6 of 6 factors measured

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: HIGH · 6 of 6 factors measured · Thu Sep 24 · market closed · Markets closed · resumes Fri 9:30 ET

Share on X →

Veridion Score History · 90D

AI Analysis

Sovereign

Why is DGX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move DGX next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Congress / Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Sep 24
Score
Score moved +13
62/Upper range -> 75/Highest qualified
Veridion score historySource
Mar 30
CongressChecking access
Alan Armstrong purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Mar 27
CongressChecking access
Alan Armstrong purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Oct 30
CongressChecking access
Julie Johnson purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Oct 30
CongressChecking access
Julie Johnson sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jul 24
CongressChecking access
Julia Letlow sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Apr 28
CongressChecking access
Julia Letlow purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Mar 10
CongressChecking access
Carol D. Miller sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access

About Quest Diagnostics Inc

SERVICES-MEDICAL LABORATORIES

Listed since

1996

Employees

57K

Country

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$234.08

Day high

$237.29

Day low

$233.55

Previous close

$233.00

52W high

$247.45

-4.39% from high

52W low

$173.49

85% of range

Market cap

$25.7B

P/E

24.37×

EPS

$9.71

Beta

-0.33

Shares out

110.4M

Volume

926.9K

0.92× rel vol

Avg volume

VWAP

$236.12

Price history computed in-house

-4.00%

-3.43%

+12.73%

+27.62%

YTD

+36.34%

SMA 50 $235.17 · above

SMA 200 $204.51 · above

52W position 85%

DGX overview

Veridion Score

Registered · 2026-09-24

6 of 6 factors measured

Latest receipt rows

Alan Armstrong · Purchase

13F holders

None on file

Relationship mapTrace receipt-backed holders and filings around DGX.Congress disclosuresOpen receipt and filing context for DGX.MethodologyReview score inputs, coverage rules, and limitations.

SEC Form 4 ledger

DGX insider activity

Quest Diagnostics Inc

Score

Not evaluated

Pressure

Not evaluated

Filings

Buys / sells

0 / 0

Net value

Not evaluated

Insiders

Cluster

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked

Net pressure

Not evaluated: no value-bearing Form 4 rows are loaded.

Convergence not evaluated

No value-bearing Form 4 rows are loaded, so cross-source convergence is not evaluated.

Form 4 evidence state

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in DGX

Congress tracker Open ticker disclosure ledger →

Alan ArmstrongBuyself

Quest Diagnostics Incorporated Common Stock · Transaction Mar 30, 2026 · Filed Jul 21, 2026 · $1,001 to $15,000

Official filing ↗

Alan ArmstrongBuyself

Quest Diagnostics Incorporated Common Stock · Transaction Mar 27, 2026 · Filed Jul 21, 2026 · $1,001 to $15,000

Official filing ↗

Julie JohnsonSelljoint

Quest Diagnostics Incorporated Common Stock · Transaction Nov 3, 2025 · Filed Dec 11, 2025 · $1,001 to $15,000

Official filing ↗

Julie JohnsonBuyjoint

Quest Diagnostics Incorporated Common Stock · Transaction Oct 30, 2025 · Filed Aug 5, 2026 · $1,001 to $15,000

Official filing ↗

Julie JohnsonSelljoint

Quest Diagnostics Incorporated Common Stock · Transaction Oct 30, 2025 · Filed Aug 5, 2026 · $1,001 to $15,000

Official filing ↗

Federal contracts